Cerebrospinal fluid monoamines in Prader–Willi syndrome
- 1 December 1998
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 44 (12) , 1321-1328
- https://doi.org/10.1016/s0006-3223(97)00519-2
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cytogenetic and molecular studies in the Prader-Willi and Angelman syndromes: An overviewAmerican Journal of Medical Genetics, 1993
- FISH ordering of reference markers and of the gene for the α5 subunit of the γ-aminobutyric acid receptor (GABRA5) within the Angelman and Prader–Willi syndrome chromosomal regionsHuman Molecular Genetics, 1993
- PRADER‐WILLI SYNDROME IN A SWEDISH RURAL COUNTY: EPIDEMIOLOGICAL ASPECTSDevelopmental Medicine and Child Neurology, 1991
- The Role of Serotonin in Eating DisordersDrugs, 1990
- Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial.Archives of Disease in Childhood, 1990
- Impaired Cholecystokinin Secretion in Bulimia NervosaNew England Journal of Medicine, 1988
- Emotional symptoms in Prader‐Willi syndrome adolescentsAmerican Journal of Medical Genetics, 1987
- Deletions of Chromosome 15 as a Cause of the Prader–Willi SyndromeNew England Journal of Medicine, 1981
- Prader‐Willi syndrome and a bisatellited derivative of chromosome 15Clinical Genetics, 1980
- FenfluramineDrugs, 1975